DISCOVERIES AND INNOVATION
FDA grants accelerated approval for Vitrakvi® (larotrectinib) for the treatment of solid tumors. This is marks the second FDA-approved drug for cancers based on their genetic makeup as opposed to location in the body.
While other toddlers her age were fighting naptime, two-year-old Michelle was battling an aggressive, life-threatening cancer. Doctors at Children’s Hospital Los Angeles saved her...
The sidewalk was smooth and the sky was clear, so Sophia Cabrera took out her skateboard and went for a ride. Before she could return home, she fell, landed in a heap and broke her arm. Funny thing is, she and her family couldn’t have been happier. Falls and fractures are regular mishaps for an 8-year-old, and regular was something Sophia hadn’t been in a long time.
Only a year...
Baby Jasmine was born in late December with
hypoplastic left heart syndrome (HLHS) and had her first open-heart surgery at
five days old. She is enrolled in the groundbreaking clinical trial at
Children’s Hospital Los Angeles.
therapy could boost organ repair and delay or even prevent heart failure in
Children born with...
1 out of 68 children in the United States will be diagnosed with an Autism Spectrum Disorder (ASD). The prevalence of an ASD diagnosis grew by 72 percent between 2007 and 2011. Tech-based interventions targeted to children with autism have the potential to help solve challenges with social skills, repetitive behaviors, speech and nonverbal communications.
At the South by Southwest Interactive Healthcare...
(Left to Right) Douglas Nordli, Jr., MD, CHLA Chief of Pediatric Neurology; Robert E. Shaddy, MD, CHLA Pediatrician-in-Chief; Rohit Kohli, MBBS, MS, CHLA Chief of Gastroenterology, Hepatology, and Nutrition.
This year, three physician researchers at Children’s Hospital Los Angles representing subspecialties in gastroenterology, neurology and cardiology, have been elected to the membership of...
David Warburton is among the 2017 AAAS Elected Fellows Recognized for Advancing Science in the Section of Medical Sciences
David Warburton, MD, has been elected a 2017 Fellow of the American Association for the Advancement of Science (AAAS) in recognition his contributions to innovation, education, and scientific leadership in the Section of Medical Sciences...